PURR
Hyperliquid Strategies Inc Common StockNASDAQFINANCIAL SERVICESCAPITAL MARKETS
Key Statistics
Market Cap
$665.71M
P/E Ratio
—
EPS
—
Beta
—
52W High
$6.63
52W Low
$3.01
50-Day MA
$4.82
200-Day MA
$4.29
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Hyperliquid Strategies Inc Common Stock
Hyperliquid Strategies Inc., through its subsidiary, is a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | -50388.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.75 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $123.97M |
| Float | 0 |
| % Insiders | 4.48% |
| % Institutions | 25.11% |
Analyst Ratings
Consensus ($7.22 target)
2
BuyData last updated: 4/9/2026